Companies Dominating the Loop-Mediated Isothermal Amplification (LAMP) Landscape
-
Thermo Fisher Scientific
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Rad Laboratories, Inc.
- New England Biolabs, Inc.
- Nippon Gene Co., Ltd.
- Omega Bio-tek, Inc.
- LGC Limited
- Excellgen.com
- Meridian Bioscience, Inc.
- HiberGene Diagnostics
- Jena Bioscience GmbH
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of loop-mediated isothermal amplification is assessed at USD 134.69 million.
The loop-mediated isothermal amplification market size was valued at USD 123.01 million in 2024 and is expected to reach USD 256.01 million by 2037, expanding at around 5.8% CAGR during the forecast period i.e., between 2025-2037. The increasing prevalence of chronic diseases and infection-related illnesses will fuel the market growth.
North America industry is estimated to dominate majority revenue share of 39% by 2037, attributed to increasing frequency of people being diagnosed with chronic diseases generating the need for loop-mediated isothermal amplification as a point-of-care genetic testing for treatment purposes.
The major players in the market are Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Nippon Gene Co., Ltd., Omega Bio-tek, Inc., LGC Limited, Excellgen.com, Meridian Bioscience, Inc., HiberGene Diagnostics, Jena Bioscience GmbH
